Webinar: How to Support Latino Cancer Survivors


latino cancer survivor webinar - horiz
Share On Social!

Latinos with cancer face a challenging survivorship journey.

Find new ways to address these cancer survivorship challenges at UT Health San Antonio’s webinar, “How to Support Latino Cancer Survivors,” at 11 a.m. Central on Monday, July 15, 2024.

The webinar will feature experts from the Mays Cancer Center at UT Health San Antonio, Genentech, as well as cancer survivors and safety-net organizations, who will explore cancer among Latinos and how to help them on the road to recovery.

Topics will cover patient advocacy, support groups, clinical trials, referrals to resources through screening for social determinants of health, and more.

This is a part of a webinar series, “Let’s Address Health Equity Together.”

The series is a collaboration of the Salud America! program at the Institute for Health Promotion Research at UT Health San Antonio, the Mays Cancer Center at UT Health San Antonio, and Genentech.

register for the webinar!

Learn about the Speakers for this Webinar on Supporting Cancer Survivors

Here are the panelists for the webinar.

After brief panelist presentations, a discussion will follow, moderated by Dr. Amelie Ramirez.

amelie ramirezDr. Amelie G. Ramirez (moderator) is an internationally recognized researcher in Latino health promotion. She is director of Salud America! and its home base, the Institute for Health Promotion Research in the Department of Population Health Sciences at UT Health San Antonio. Ramirez has spent over 30 years directing research on human and organizational communication to reduce chronic disease and cancer health disparities affecting Latinos, including cancer risk factors, clinical trial recruitment, tobacco prevention, obesity prevention, and promotion of health equity. She also is associate director of cancer outreach and engagement at the NCI-designated Mays Cancer Center at UT Health San Antonio.

Adolfo Diaz DuqueDr. Adolfo Diaz Duque is a hematologist-oncologist at the NCI-designated Mays Cancer Center at UT Health San Antonio, where he serves as an associate professor in the Department of Medicine with the Division of Hematology-Oncology. He completed his Hematology-Oncology Fellowship and received a master’s degree in clinical investigation and translational science degree from UT Health San Antonio. His research and clinical interest focus on improving outcomes in patients with lymphomas and on health care disparities and underrepresented minorities. At the Mays Cancer Center, he is developing a research program investigating novel therapies in Hodgkin’s lymphoma and non-Hodgkin’s lymphoma. He currently serves as the institutional leader for several investigator-initiated, industry-sponsored, and cooperative group studies, and serves as Hematology Clinical Disease Site Team (CDST) lead since mid-2018. In parallel, he also serves as an Ambassador for the American Society of Hematology (ASH) since 2016.

Marielle Santos McLeodMarielle Santos McLeod is a prominent figure in the realm of advocacy, particularly as a Latino Cancer Patient Advocate. Her extensive background encompasses roles in the public, private, and non-profit sectors, providing her with a multifaceted perspective that enhances her effectiveness in the field. Surviving Stage III colon cancer has not only fueled McLeod’s passion but also instilled in her a profound understanding of the vital role peer support plays in the cancer journey. Drawing upon her personal experience, she has dedicated over six years to serving as a Peer Support Program Manager and Certified Bilingual Patient & Family Support Navigator within the national non-profit sector. Through her role, McLeod tirelessly works to connect with and support cancer patients, caregivers, and volunteers across the nation, fostering a sense of community and understanding. Beyond her direct involvement in support programs, McLeod is a fervent advocate, utilizing her platforms to raise awareness about the critical need for proper medical access in underserved communities. Her commitment to amplifying the voices of those facing healthcare disparities is evident in her advocacy efforts, making a meaningful impact on the lives of those she serves.

Erin Ercoline Erin Ercoline is the leader of the ThriveWell Cancer Foundation, founded in 2007 in San Antonio, Texas. Thrivewell is dedicated to finding a cure for cancer by funding cancer research, providing patient support and offering programs to improve the quality of life for patients and their families. The organization runs a patient assistance program is focused on enabling cancer patients to comply with their prescribed treatment plan by providing transportation, financial and lodging assistance to those in need. The goal is to give patients the best possible chance of beating the disease while eliminating the added stressors that go hand-in-hand with cancer. Through the end of 2023, ThriveWell provided more than $11.5 million to patients, paying for their treatment costs, transportation and lodging since the inception of the program.

register for the webinar!

Behind the Webinar Series on Health Equity

The “Let’s Address Health Equity Together” webinar series is a collaboration of the Salud America! program at the Institute for Health Promotion Research at UT Health San Antonio, the Mays Cancer Center at UT Health San Antonio, and Genentech.

Three webinars are planned for 2024.

Four webinars occurred in 2023, and six occurred from 2021-2022.

Salud America! is a national Latino-focused organization that creates culturally relevant and research-based stories, videos, and tools to inspire people to start and support healthy changes to policies, systems, and environments where Latino children and families can equitably live, learn, work, and play.

The Mays Cancer Center, also known as the UT Health San Antonio MD Anderson Cancer Center, has a mission to decrease the burden of cancer in San Antonio, South Texas and beyond. We bring South Texas a level of exceptional care that is comparable with the nation’s most respected programs. More patients put their trust in our program because we have a unique understanding of our community’s cancer care needs. We excel in delivering advanced therapies.

Founded more than 40 years ago as the first biotechnology company, Genentech is dedicated to the rigorous pursuit of science and the development and delivery of life-changing medicines for people facing serious diseases. Headquartered in South San Francisco, California and a proud member of the Roche Group, our community is united by a common purpose and sense of urgency to transform the future of healthcare. Learn more at gene.com.

register for the webinar!

Explore More:

Cancer, Clinical Trials

By The Numbers By The Numbers



Expected rise in Latino cancer cases in coming years

Share your thoughts